Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T03:23:13.322Z Has data issue: false hasContentIssue false

Chromosomal Evidence of Donor Cells Proliferation following Bone Marrow Transplantation

Published online by Cambridge University Press:  01 August 2014

G. Schwanitz*
Affiliation:
Institut für Humangenetik undAnthropologie der Universität, Erlangen-Nürnberg Medizinische Klinik derUniversität Erlangen-Nürnberg
G. Hartwich*
Affiliation:
Institut für Humangenetik undAnthropologie der Universität, Erlangen-Nürnberg Medizinische Klinik derUniversität Erlangen-Nürnberg
J. Becker*
Affiliation:
Institut für Humangenetik undAnthropologie der Universität, Erlangen-Nürnberg Medizinische Klinik derUniversität Erlangen-Nürnberg
*
Institut für Humangenetik undAnthropologie der Universität Erlangen-Nürnberg, Bismarckstrasse 26/11, 8520 Erlangen, Deutschland
Medizinische Klinik derUniversität Erlangen-Nürnberg, Krankenhausstrasse 12, 8520 Erlangen, Deutschland
Medizinische Klinik derUniversität Erlangen-Nürnberg, Krankenhausstrasse 12, 8520 Erlangen, Deutschland

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

After an intense cytostatic treatment of the patient F.N., whose bone marrow was completely infiltrated with lympho-sarcocytes, a bone marrow transplantation was made. The donor was the patient's sister. The difference in sex chromosomes made it possible to observe the fate of the transferred cells. Immediately after the treatment, till 6½ months later, cells with feminine caryotype were traceable in the patient's peripheral blood (up to 2%). This proves the proliferation of donor cells in the acceptor.

Type
Research Article
Copyright
Copyright © The International Society for Twin Studies 1969

References

Literatur

Beilby, J. O. W., Cade, I. S., Jelliffe, A. M., Parkin, D. M., Stewart, J. W. (1960). Prolonged survival of a bone-marrow graft resulting in a blood-group chimera. Brit. Med. J., 1: 96.Google Scholar
Dunnigan, M. G., Brown, A. (1963). Autologous bone marrow and large doses of malignant disease. Report of a controlled trial. Lancet, 2: 477.Google Scholar
Gebhart, E. (1967). Untersuchungen über die cytogenetische Wirkung einiger Vaginalantikonzipienten und ihrer Hauptwirkstoffe. Diss. München.Google Scholar
Gebhart, E. (1969). Chromosomenaberrationen durch Myleran in menschlichen Leukocyten in vitro. Humangenetik, 7: 126.Google ScholarPubMed
Hampel, K. E. (1968). Über die Wirkung von Zytostatica auf die Chromosomen des Menschen. Int. J. Clin. Pharmacol., 14: 322.Google Scholar
Heller, P., Yakulis, V. (1958). Bone marrow transplants. Lancet, 1: 1131.CrossRefGoogle Scholar
Kurnick, N. B. (1962). Autologous and isologous bone marrow therapy in man. Bone marrow therapy and protection in irradiated primates. Rijswijk, 289.Google Scholar
Moorhead, P. S., Nowell, P. C., Mellman, W. J., Battips, D. M., Hungerford, D. A. (1960). Chromosome preparations of leukocytes cultured from human peripheral blood. Exp. Cell. Res., 20: 613.Google Scholar
Schwanitz, G., Wolf, F., Koch, G. (1968). Aberraciones cromosomicas y alteraciones mitosicas después de tratamiento combinado con radioyodo y radiaciones Röntgen. Folia Clin. Int. (Barc.), 18: 3.Google Scholar
Witte, S. (1963). Die Knochenmarkstransfusion. Lehmanns Verlag, München.Google Scholar
Witte, S. (1968). Knochenmarkstransplantation. In Betke, K. und Tosberg, P.: Das Knochenmark. Lehmanns Verlag, München.Google Scholar